Length of stay in intensive care unit and characteristics of COVID-19 patients: a single-center observational retrospective study in Hospital Metropolitano, Quito, Ecuador
DOI:
https://doi.org/10.47464/MetroCiencia/vol30/1/2022/49-60Palabras clave:
coronavirus; covid-19; intensive care unit; mortality; EcuadorResumen
Introduction: COVID-19 has been identified by the World Health Organization as a global pandemic. Objectives: The study aims at presenting data on COVID-19 hospitalization cases from march 2020 to January 2021 in Hospital Metropolitano of Quito, Ecuador. Methods: Retrospective study in 515 hospitalization records from adult subjects. Results: We included 332 males and 183 females, 91 patients were admitted to the intensive care unit (ICU) and the mean (±SD) length of ICU stay was 13.5 ± 8.2 days and mean (±SD) length of hospital stay was 5.9 (±3.3) days. It was observed 7.2% of deaths. Thirty-four percent of the patient admitted in ICU died and had a higher mean age compared to survivors (65.6 ± 13.4 vs 56.3 ± 16.1, P = 0.000). The most prevalent comorbidities were hypertension, hypothyroidism and diabetes. There were significant differences in the neutrophil counts, D-dimer levels, creatinine, glucose, IL6, triglycerides (TGL), lactate dehydrogenase (LDH), troponin, sodium and potassium count between survivors and non survivors. The most frequent symptoms were dyspnea, fever and cough. Conclusions: Patients admitted to the intensive care unit had longer length of stay, were older and with lower oxygen saturation level. The laboratory parameters were significantly higher in patients who died. Abnormal count of neutrophils and LDH as well as age were risk factors for mortality in these patients.
Descargas
Citas
Statistics. coronavirusecuador.com/estadisticas-covid-19/.
Parra M, Carrera E. Evolución de la COVID-19 en Ecuador. Investigación & Desarrollo, [S.l.], v. 13, n. 1, p. 28-42, dic. 2020. ISSN 2631-2557. Disponible en: <https://revistas.uta.edu.ec/erevista/index.php/dide/article/view/1002>. Fecha de acceso: 19 feb. 2021)
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24. PMID: 31978945; PMCID: PMC7092803
Risk Factors for COVID-19 Disease Progression. Massachusetts General Hospital. March/April, 2020
Ali H, Alshukry A, Bu Abbas M, Ali Y, Alahmad B, Al-Shammari AA, et al. Clinical Characteristics and Outcomes of Diabetic COVID-19 patients in Kuwait. medRxiv. 2020:2020.08.20.20178525. 10.1101/2020.08.20.2017852 Ruan S. Likelihood of survival of coronavirus disease 2019. Lancet Infect Dis. 2020;20(6):630–631
Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia. 2020 Oct;75(10):1340-1349. doi: 10.1111/anae.15201. Epub 2020 Jul 15. PMID: 32602561.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. PMID: 32250385; PMCID: PMC7136855.
Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Bordell A, Adalia R, Zattera L, Ramasco F, Monedero P, Maseda E, Martínez A, Tamayo G, Mercadal J, Muñoz G, Jacas A, Ángeles G, Castro P, Hernández-Tejero M, Fernandez J, Gómez-Rojo M, Candela Á, Ripollés J, Nieto A, Bassas E, Deiros C, Margarit A, Redondo FJ, Martín A, García N, Casas P, Morcillo C, Hernández-Sanz ML; de la Red de UCI Española para COVID-19. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim. 2020 Oct;67(8):425-437. English, Spanish. doi: 10.1016/j.redar.2020.07.003. Epub 2020 Jul 13. PMID: 32800622; PMCID: PMC7357496.
Ballaz SJ, Pulgar-Sánchez M, Chamorro K, Fernández-Moreira E, Ramírez H, Mora FX, Fors M. Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR). Clin Chem Lab Med. 2021 Mar 5. doi: 10.1515/cclm-2021-0156. Epub ahead of print. PMID: 33675191.
Alnor, A, Sandberg, MB, Gils, C, Vinholt, PJ. Laboratory tests and outcome for patients with Coronavirus disease 2019: a systematic review and meta-analysis. J Appl Lab Med 2020;5:1038–49
Pirsalehi A, Salari S, Baghestani A, Sanadgol G, Shirini D, Baerz MM, Abdi S, Akbari ME, Bashash D. Differential alteration trend of white blood cells (WBCs) and monocytes count in severe and non-severe COVID-19 patients within a 7-day follow-up. Iran J Microbiol. 2021 Feb;13(1):8-16. doi: 10.18502/ijm.v13i1.5486. PMID: 33889357; PMCID: PMC8043835.
Ten-Caten F, Gonzalez-Dias P, Castro Í, Ogava RLT, Giddaluru J, Silva JCS, Martins F, Gonçalves ANA, Costa-Martins AG, Araujo JD, Viegas AC, Cunha FQ, Farsky S, Bozza FA, Levin AS, Pannaraj PS, de Silva TI, Minoprio P, Pinheiro da Silva F, Andrade BB, Nakaya HI. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19. Int J Infect Dis. 2021 Apr;105:579-587. doi: 10.1016/j.ijid.2021.03.016. Epub 2021 Mar 10. PMID: 33713813; PMCID: PMC7944763.
Jin J.-M., Bai P., He W. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.
Meng Y., Wu P., Lu W. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520.
Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: A systematic review and meta-analysis. J Med Virol. 2021 Jan;93(1):257-261. doi: 10.1002/jmv.26237. Epub 2020 Oct 5. PMID: 32603481; PMCID: PMC7361606.
Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020. 10.1002/oby.2283
Finer N, Garnett SP, Bruun JM. COVID-19 and obesity. Clin Obes. 2020 Jun;10(3):e12365. doi: 10.1111/cob.12365. Epub 2020 Apr 27. PMID: 32342637; PMCID: PMC7267455.
Pranata R, Lim MA, Yonas E, Vania R, Lukito AA, Siswanto BB, Meyer M. Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis. Diabetes Metab. 2021 Mar;47(2):101178. doi: 10.1016/j.diabet.2020.07.005. Epub 2020 Jul 29. PMID: 32738402; PMCID: PMC7388778
.
Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, Fernainy K, Andersen S, Mercado L, Guan J, Zafar H, Louzon P, Carr A, Baloch N, Pratley R, Silverstry S, Hsu V, Sniffen J, Herrera V, Finkler N. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS One. 2021 Mar 25;16(3):e0249038. doi: 10.1371/journal.pone.0249038. PMID: 33765049; PMCID: PMC7993561.
Singh P, Warren K, Adler H, Mangano A, Sansbury J, Duff R. A Retrospective Review of Outcomes in Intensive Care Unit Patients Infected With SARS-Cov2 in Correlation to Admission Acute Physiologic Assessment and Chronic Health Evaluation II Scores. Cureus. 2021 Mar 23;13(3):e14051. doi: 10.7759/cureus.14051. PMID: 33777587; PMCID: PMC7985663.
Pouw N, van de Maat J, Veerman K, Ten Oever J, Janssen N, Abbink E, Reijers M, de Mast Q, Hoefsloot W, van Crevel R, Slieker K, van Apeldoorn M, Blaauw M, Dofferhoff A, Hoogerwerf J. Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study. PLoS One. 2021 Mar 18;16(3):e0248713. doi: 10.1371/journal.pone.0248713. PMID: 33735205; PMCID: PMC7971488
Bellan M, Patti G, Hayden E, Azzolina D, Pirisi M, Acquaviva A, Aimaretti G, Aluffi Valletti P, Angilletta R, Arioli R, Avanzi GC, Avino G, Balbo PE, Baldon G, Baorda F, Barbero E, Baricich A, Barini M, Barone-Adesi F, Battistini S, Beltrame M, Bertoli M, Bertolin S, Bertolotti M, Betti M, Bobbio F, Boffano P, Boglione L, Borrè S, Brucoli M, Calzaducca E, Cammarata E, Cantaluppi V, Cantello R, Capponi A, Carriero A, Casciaro FG, Castello LM, Ceruti F, Chichino G, Chirico E, Cisari C, Cittone MG, Colombo C, Comi C, Croce E, Daffara T, Danna P, Della Corte F, De Vecchi S, Dianzani U, Di Benedetto D, Esposto E, Faggiano F, Falaschi Z, Ferrante D, Ferrero A, Gagliardi I, Gaidano G, Galbiati A, Gallo S, Garavelli PL, Gardino CA, Garzaro M, Gastaldello ML, Gavelli F, Gennari A, Giacomini GM, Giacone I, Giai Via V, Giolitti F, Gironi LC, Gramaglia C, Grisafi L, Inserra I, Invernizzi M, Krengli M, Labella E, Landi IC, Landi R, Leone I, Lio V, Lorenzini L, Maconi A, Malerba M, Manfredi GF, Martelli M, Marzari L, Marzullo P, Mennuni M, Montabone C, Morosini U, Mussa M, Nerici I, Nuzzo A, Olivieri C, Padelli SA, Panella M, Parisini A, Paschè A, Pau A, Pedrinelli AR, Percivale I, Re R, Rigamonti C, Rizzi E, Rognoni A, Roveta A, Salamina L, Santagostino M, Saraceno M, Savoia P, Sciarra M, Schimmenti A, Scotti L, Spinoni E, Smirne C, Tarantino V, Tillio PA, Vaschetto R, Vassia V, Zagaria D, Zavattaro E, Zeppegno P, Zottarelli F, Sainaghi PP. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep. 2020 Nov 26;10(1):20731. doi: 10.1038/s41598-020-77698-4. PMID: 33244144; PMCID: PMC7692524.
Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (Lond, Engl) 2020;395(10229):1054–1062.
Aggarwal S., Garcia-Telles N., Aggarwal G., Lavie C., Lippi G., Henry B.M. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis (Berlin, Germany) 2020;7(2):91–96.
Lippi G, Wong J, Henry B. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130(4):304–9. [PubMed]Lippi G, Wong J, Henry B. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130(4):304–9.
van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, Sinclair CF, Genden E. Outcomes of patients with hypothyroidism and COVID-19: a retrospective cohort study. Front Endocrinol (Lausanne) 11: 565, 2020. doi:10.3389/fendo.2020.00565
Daraei M, Hasibi M, Abdollahi H, Mirabdolhagh Hazaveh M, Zebaradst J, Hajinoori M, Asadollahi-Amin A. Possible role of hypothyroidism in the prognosis of COVID-19. Intern Med J. 2020 Nov;50(11):1410-1412. doi: 10.1111/imj.15000. PMID: 33215834; PMCID: PMC7753499.
Mitra AR, Fergusson NA, Lloyd-Smith E, Wormsbecker A, Foster D, Karpov A, Crowe S, Haljan G, Chittock DR, Kanji HD, Sekhon MS, Griesdale DEG. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series. CMAJ. 2020 Jun 29;192(26):E694-E701. doi: 10.1503/cmaj.200794. Epub 2020 May 27. PMID: 32461326; PMCID: PMC7828881.
Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, Li T, Margolick JB, Pawelec G, Leng SX. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31. PMID: 33137510; PMCID: PMC7604159.
Seo JW, Kim SE, Choi EY, Hong KS, Oh TH, Kim UJ, Kang SJ, Park KH, Jung SI, Kim DY, Yun NR, Kim DM, Kim HP, Hur J, Jang HC. Risk Factors and a Scoring System to Predict ARDS in Patients with COVID-19 Pneumonia in Korea: A Multicenter Cohort Study. Dis Markers. 2021 Apr 9;2021:8821697. doi: 10.1155/2021/8821697. PMID: 33897912; PMCID: PMC8052177.
Chowdhury MEH, Rahman T, Khandakar A, Al-Madeed S, Zughaier SM, Doi SAR, Hassen H, Islam MT. An Early Warning Tool for Predicting Mortality Risk of COVID-19 Patients Using Machine Learning. Cognit Comput. 2021 Apr 21:1-16. doi: 10.1007/s12559-020-09812-7. Epub ahead of print. PMID: 33897907; PMCID: PMC8058759
Orlacchio A, Gasparrini F, Roma S, Ravà MS, Salvatori E, Morosetti D, Cossu E, Legramante JM, Paganelli C, Bernardini S, Minieri M. Correlations between chest-CT and laboratory parameters in SARS-CoV-2 pneumonia: A single-center study from Italy. Medicine (Baltimore). 2021 Apr 9;100(14):e25310. doi: 10.1097/MD.0000000000025310. PMID: 33832103; PMCID: PMC8036082.
Qin L., Li X., Shi J. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan. J Med Virol. 2020 doi: 10.1002/jmv.26137.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Cecilia Farinango, Fabián Altamirano, César Delgado, Martha Fors Lopez
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
